经腹膜后植入脂多糖渗透泵系统诱导大鼠腹主动脉瘤新方法
研究将20只10月龄雄性Sprague-Dawley大鼠随机分为空白组2只、假手术组4只、空胶囊组4只和LPS胶囊组10只,经腹膜后植入含LPS(3.6 μg/天)的ALZET渗透泵胶囊,2周后从LPS胶囊组随机选6只植入IL-10(75 ng/天)渗透泵胶囊作为抗炎组。结果显示LPS胶囊组在6周内出现持续显著主动脉扩张(P < 0.01),抗炎组在IL-10植入2周后迅速明显缩小(P < 0.01)。
要点
- LPS胶囊组6周内主动脉持续显著扩张(P < 0.01),抗炎组IL-10植入2周后迅速明显缩小(P < 0.01)。
- LPS胶囊组病理模仿人类腹主动脉瘤,第6周末中膜退变最重、弹性蛋白含量在5组中最低(P < 0.05)。
- 抗炎组中膜保存完好、弹性蛋白含量最多(P < 0.05)且弹性蛋白/胶原比值最高(P < 0.01)。
核心结论
- 经腹膜后植入含LPS渗透泵胶囊诱导大鼠腹主动脉瘤的新方法可同时模仿人类腹主动脉瘤的组织学特征和自然病史。
- 需要进一步研究改进渗透泵系统。
研究设计与样本
- 研究将20只10月龄雄性Sprague-Dawley大鼠随机分为空白组2只、假手术组4只、空胶囊组4只和LPS胶囊组10只。
- LPS胶囊组经腹膜后入路在腹主动脉旁植入含LPS(3.6 μg/天)的ALZET渗透泵胶囊。
- 2周后从LPS胶囊组随机选6只作为抗炎组,经同一入路植入含IL-10(75 ng/天)的渗透泵胶囊。
- 每2周超声观察腹主动脉直径变化,6周后取材行组织病理学和免疫组化分析。
主要发现
- 建模后6周内LPS胶囊组出现持续显著主动脉扩张(P < 0.01)。
- 抗炎组在IL-10渗透泵胶囊植入2周后出现迅速明显缩小(P < 0.01)。
- LPS胶囊组病理模仿人类腹主动脉瘤良好,第6周末中膜退变严重且弹性蛋白含量在5组中最低(P < 0.05)。
- 抗炎组第6周末中膜保存完好、弹性蛋白含量最多(P < 0.05)且弹性蛋白/胶原比值最高(P < 0.01)。
- 第6周末LPS胶囊组MMP2、MMP9和TLR2强表达,显著高于空白组和假手术组;抗炎组MMP9表达略高于LPS胶囊组但无统计学差异。
局限性
- 需要进一步研究改进渗透泵系统。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Few methods can cocurrently mimic the pathological characteristics and nature history of human abdominal aortic aneurysms (AAAs), especially for the exist of the self-healing tendency of rodents. This study tested a novel method for the AAA rat model induced by retroperitoneal implantation of an osmotic pump system with lipopolysaccharide (LPS) based on the hypothesis that chronic inflammation of perivascular adipose tissue directly influenced the development and progression of AAAs. METHODS: 20 male Sprague-Dawley rats (10-month-old) fed with the Paigen diet were randomly divided into 4 groups: the blank group ×2, the sham group ×4, the empty capsule group ×4, and the LPS capsule group ×10. The LPS capsule group received implantations of the ALZET® osmotic pump capsule with LPS (3.6 μg/day) parallel to the abdominal aorta through a retroperitoneal approach. Two weeks later, 6 rats were randomly selected from the LPS capsule group to form the anti-inflammatory group and received implantations of another osmotic pump capsule with interleukin (IL)-10 (75 ng/day) through the same approach. The changes in abdominal aortic diameter were observed by ultrasound every 2 weeks, and samples were harvested for histopathologic and immunohistochemical analysis 6 weeks later. RESULTS: Within the 6 weeks after modeling, the LPS capsule group showed sustained and significant aortic dilatation (P < 0.01), while the anti-inflammatory group showed a rapid and obvious shrinkage 2 weeks after the IL-10 osmotic pump capsule implantation (P < 0.01). The LPS capsule group presented excellent pathological mimicking of human AAAs and showed severe medial degeneration with the least elastic content among the 5 groups at the end of the sixth week (P < 0.05). Notably, the anti-inflammatory group showed perfect medial preservation with the most elastic content (P < 0.05) and the highest elastin/collagen ratio (P < 0.01) at the end of the study. Matrix metalloproteinases (MMP) 2 and 9 and toll-like receptor 2 showed strong expression in the LPS capsule group at the end of the sixth week, which was significantly higher than that in the blank group and sham group. Interestingly, the anti-inflammatory group showed a slightly higher MMP9 expression than the LPS capsule group though there was no statistical difference between them. CONCLUSIONS: This novel method for the rat AAA model induced by retroperitoneal implantation of an osmotic pump capsule with LPS can concurrently mimic the histological characteristics and natural history of human AAAs. Further studies were needed to improve the osmotic pump system.
引用
- Gao JP, Zhang HP, Wei R, et al. A Novel Method for the Rat Model of Abdominal Aortic Aneurysm Induced by Retroperitoneal Implantation of an Osmotic Pump System With Lipopolysaccharide. Ann Vasc Surg. 2023. PMID: 38154490. doi:10.1016/j.avsg.2023.11.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。